Cargando…

BAP1 and PBRM1 in metastatic clear cell renal cell carcinoma: tumor heterogeneity and concordance with paired primary tumor

BACKGROUND: BAP1 and PBRM1 are frequently mutated in primary clear cell renal cell carcinoma (ccRCC) tumors; however, the frequency and clinical relevance of these mutations in metastatic ccRCC tumors is unknown. Additionally, while intra-tumor heterogeneity has been shown to be common in primary cc...

Descripción completa

Detalles Bibliográficos
Autores principales:	Eckel-Passow, Jeanette E., Serie, Daniel J., Cheville, John C., Ho, Thai H., Kapur, Payal, Brugarolas, James, Thompson, R. Houston, Leibovich, Bradley C., Kwon, Eugene D., Joseph, Richard W., Parker, Alexander S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2017
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5361787/ https://www.ncbi.nlm.nih.gov/pubmed/28327121 http://dx.doi.org/10.1186/s12894-017-0209-3

Ejemplares similares

Concordance of PD‐1 and PD‐L1 (B7‐H1) in paired primary and metastatic clear cell renal cell carcinoma
por: Eckel‐Passow, Jeanette E., et al.
Publicado: (2019)

Multicenter Validation of Enhancer of Zeste Homolog 2 Expression as an Independent Prognostic Marker in Localized Clear Cell Renal Cell Carcinoma
por: Ho, Thai Huu, et al.
Publicado: (2017)

ANKS1B is a smoking-related molecular alteration in clear cell renal cell carcinoma
por: Eckel-Passow, Jeanette E, et al.
Publicado: (2014)

Loss of histone H3 lysine 36 trimethylation is associated with an increased risk of renal cell carcinoma-specific death
por: Ho, Thai H., et al.
Publicado: (2015)

8q24 clear cell renal cell carcinoma germline variant is associated with VHL mutation status and clinical aggressiveness
por: Eckel-Passow, Jeanette E., et al.
Publicado: (2020)

Expression and Mutation Patterns of PBRM1, BAP1 and SETD2 Mirror Specific Evolutionary Subtypes in Clear Cell Renal Cell Carcinoma()
por: Bihr, Svenja, et al.
Publicado: (2019)

Mutational Analysis of PBRM1 and Significance of PBRM1 Mutation in Anti-PD-1 Immunotherapy of Clear Cell Renal Cell Carcinoma
por: Aili, Abudureyimujiang, et al.
Publicado: (2021)

Aberrant promoter hypermethylation of PBRM1, BAP1, SETD2, KDM6A and other chromatin-modifying genes is absent or rare in clear cell RCC
por: Ibragimova, Ilsiya, et al.
Publicado: (2013)

Computational analysis of the mutations in BAP1, PBRM1 and SETD2 genes reveals the impaired molecular processes in renal cell carcinoma
por: Piva, Francesco, et al.
Publicado: (2015)

Functional role of SETD2, BAP1, PARP-3 and PBRM1 candidate genes on the regulation of hTERT gene expression
por: Linne, Hannah, et al.
Publicado: (2017)

Prognostic and Predictive Value of PBRM1 in Clear Cell Renal Cell Carcinoma
por: Carril-Ajuria, Lucía, et al.
Publicado: (2019)

A Pan-Cancer Analysis of the Role of PBRM1 in Human Tumors
por: Liu, Jin, et al.
Publicado: (2022)

PBRM1 Immunohistochemical Expression Profile Correlates with Histomorphological Features and Endothelial Expression of Tumor Vasculature for Clear Cell Renal Cell Carcinoma
por: Saiga, Kazuho, et al.
Publicado: (2022)

Recent Advances in Renal Tumors with TSC/mTOR Pathway Abnormalities in Patients with Tuberous Sclerosis Complex and in the Sporadic Setting
por: Kapur, Payal, et al.
Publicado: (2023)

PBRM1 suppresses tumor growth as a novel p53 acetylation reader
por: Cai, Weijia, et al.
Publicado: (2020)

PBRM1 Regulates the Expression of Genes Involved in Metabolism and Cell Adhesion in Renal Clear Cell Carcinoma
por: Chowdhury, Basudev, et al.
Publicado: (2016)

Germline mutations in BAP1 predispose to melanocytic tumors
por: Wiesner, Thomas, et al.
Publicado: (2011)

An Atypical Presentation of BAP1-Inactivated Melanocytic Tumor
por: Herrero-Ruiz, Sara Pilar, et al.
Publicado: (2023)

Development and validation of a PBRM1‐associated immune prognostic model for clear cell renal cell carcinoma
por: Chen, Jiayi, et al.
Publicado: (2021)

PBRM1 and the glycosylphosphatidylinositol biosynthetic pathway promote tumor killing mediated by MHC-unrestricted cytotoxic lymphocytes
por: Menasche, Bridget L., et al.
Publicado: (2020)

PBRM1 acts as a p53 lysine-acetylation reader to suppress renal tumor growth
por: Cai, Weijia, et al.
Publicado: (2019)

BAP1 loss defines a new class of renal cell carcinoma
por: Peña-Llopis, Samuel, et al.
Publicado: (2012)

Tumor suppressor BAP1 nuclear import is governed by transportin-1
por: Yang, Tzu-Jing, et al.
Publicado: (2022)

PBRM1 Regulates Stress Response in Epithelial Cells
por: Porter, Elizabeth G., et al.
Publicado: (2019)

BAP1 links metabolic regulation of ferroptosis to tumor suppression
por: Zhang, Yilei, et al.
Publicado: (2018)

An adolescent with uveal melanoma and BAP1 tumor predisposition syndrome
por: Young, Kelly Z., et al.
Publicado: (2020)

Integrated analysis of anti-tumor roles of BAP1 in osteosarcoma
por: Hu, Dong, et al.
Publicado: (2022)

Genetic characterization of Polish ccRCC patients: somatic mutation analysis of PBRM1, BAP1 and KDMC5, genomic SNP array analysis in tumor biopsy and preliminary results of chromosome aberrations analysis in plasma cell free DNA
por: Kluzek, Katarzyna, et al.
Publicado: (2017)

BAP1 tumor predisposition syndrome case report: pathological and clinical aspects of BAP1-inactivated melanocytic tumors (BIMTs), including dermoscopy and confocal microscopy
por: Soares de Sá, Bianca Costa, et al.
Publicado: (2019)

Context-dependent role for chromatin remodeling component PBRM1/BAF180 in clear cell renal cell carcinoma
por: Murakami, A, et al.
Publicado: (2017)

PBRM1 loss defines a nonimmunogenic tumor phenotype associated with checkpoint inhibitor resistance in renal carcinoma
por: Liu, Xian-De, et al.
Publicado: (2020)

PBRM1 bromodomains associate with RNA to facilitate chromatin association
por: De Silva, Saumya M, et al.
Publicado: (2023)

BAP1: case report and insight into a novel tumor suppressor
por: Ghosh, Kanad, et al.
Publicado: (2017)

Monoubiquitination of ASXLs controls the deubiquitinase activity of the tumor suppressor BAP1
por: Daou, Salima, et al.
Publicado: (2018)

Potential Role of VHL, PTEN, and BAP1 Mutations in Renal Tumors
por: Szegedi, Krisztián, et al.
Publicado: (2023)

Involvement of PBRM1 in VHL disease-associated clear cell renal cell carcinoma and its putative relationship with the HIF pathway
por: Gad, Sophie, et al.
Publicado: (2021)

Analysis of uveal melanomas and paired constitutional DNA for exclusion of a BAP1-tumor predisposition syndrome
por: Abbassi, Yasaman Arjmand, et al.
Publicado: (2022)

Urinary mRNA biomarker panel for the detection of urothelial carcinoma
por: Urquidi, Virginia, et al.
Publicado: (2016)

Relationship between body composition and PBRM1 mutations in clear cell renal cell carcinoma: a propensity score matching analysis
por: Demirel, Emin, et al.
Publicado: (2023)

A BAP1 Mutation-specific MicroRNA Signature Predicts Clinical Outcomes in Clear Cell Renal Cell Carcinoma Patients with Wild-type BAP1
por: Ge, Yu-Zheng, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_ubuvg86g7geo1l573pksm0h0ur